186 related articles for article (PubMed ID: 33855848)
1. Proteogenomic Workflow Reveals Molecular Phenotypes Related to Breast Cancer Mammographic Appearance.
De Marchi T; Pyl PT; Sjöström M; Klasson S; Sartor H; Tran L; Pekar G; Malmström J; Malmström L; Niméus E
J Proteome Res; 2021 May; 20(5):2983-3001. PubMed ID: 33855848
[TBL] [Abstract][Full Text] [Related]
2. Extracting Pathway-level Signatures from Proteogenomic Data in Breast Cancer Using Independent Component Analysis.
Liu W; Payne SH; Ma S; Fenyö D
Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S169-S182. PubMed ID: 31213479
[TBL] [Abstract][Full Text] [Related]
3. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
[TBL] [Abstract][Full Text] [Related]
4. "Association of mammographic features with molecular breast tumor profiles".
Sartor H; Zackrisson S; Hegardt C; Larsson C
Cancer Treat Res Commun; 2021; 28():100387. PubMed ID: 34004506
[TBL] [Abstract][Full Text] [Related]
5. Credentialing Individual Samples for Proteogenomic Analysis.
Zhao W; Li J; Akbani R; Liang H; Mills GB
Mol Cell Proteomics; 2018 Aug; 17(8):1515-1530. PubMed ID: 29716986
[TBL] [Abstract][Full Text] [Related]
6. Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.
Huang KL; Li S; Mertins P; Cao S; Gunawardena HP; Ruggles KV; Mani DR; Clauser KR; Tanioka M; Usary J; Kavuri SM; Xie L; Yoon C; Qiao JW; Wrobel J; Wyczalkowski MA; Erdmann-Gilmore P; Snider JE; Hoog J; Singh P; Niu B; Guo Z; Sun SQ; Sanati S; Kawaler E; Wang X; Scott A; Ye K; McLellan MD; Wendl MC; Malovannaya A; Held JM; Gillette MA; Fenyö D; Kinsinger CR; Mesri M; Rodriguez H; Davies SR; Perou CM; Ma C; Reid Townsend R; Chen X; Carr SA; Ellis MJ; Ding L
Nat Commun; 2017 Mar; 8():14864. PubMed ID: 28348404
[TBL] [Abstract][Full Text] [Related]
7. Improving Gene Annotation of the Peanut Genome by Integrated Proteogenomics Workflow.
Li H; Zhou R; Xu S; Chen X; Hong Y; Lu Q; Liu H; Zhou B; Liang X
J Proteome Res; 2020 Jun; 19(6):2226-2235. PubMed ID: 32367721
[TBL] [Abstract][Full Text] [Related]
8. Do mammographic tumor features in breast cancer relate to breast density and invasiveness, tumor size, and axillary lymph node involvement?
Sartor H; Borgquist S; Hartman L; Olsson Å; Jawdat F; Zackrisson S
Acta Radiol; 2015 May; 56(5):536-44. PubMed ID: 24814360
[TBL] [Abstract][Full Text] [Related]
9. Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.
Krug K; Jaehnig EJ; Satpathy S; Blumenberg L; Karpova A; Anurag M; Miles G; Mertins P; Geffen Y; Tang LC; Heiman DI; Cao S; Maruvka YE; Lei JT; Huang C; Kothadia RB; Colaprico A; Birger C; Wang J; Dou Y; Wen B; Shi Z; Liao Y; Wiznerowicz M; Wyczalkowski MA; Chen XS; Kennedy JJ; Paulovich AG; Thiagarajan M; Kinsinger CR; Hiltke T; Boja ES; Mesri M; Robles AI; Rodriguez H; Westbrook TF; Ding L; Getz G; Clauser KR; Fenyö D; Ruggles KV; Zhang B; Mani DR; Carr SA; Ellis MJ; Gillette MA;
Cell; 2020 Nov; 183(5):1436-1456.e31. PubMed ID: 33212010
[TBL] [Abstract][Full Text] [Related]
10. Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.
Fu S; Liu X; Luo M; Xie K; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2017 Apr; 14(4):351-362. PubMed ID: 28276747
[TBL] [Abstract][Full Text] [Related]
11. Breast carcinoma with basal phenotype: mammographic findings.
Luck AA; Evans AJ; James JJ; Rakha EA; Paish EC; Green AR; Ellis IO
AJR Am J Roentgenol; 2008 Aug; 191(2):346-51. PubMed ID: 18647900
[TBL] [Abstract][Full Text] [Related]
12. Current status of clinical proteogenomics in lung cancer.
Nishimura T; Nakamura H; Végvári Á; Marko-Varga G; Furuya N; Saji H
Expert Rev Proteomics; 2019 Sep; 16(9):761-772. PubMed ID: 31402712
[No Abstract] [Full Text] [Related]
13. Proteome-wide onco-proteogenomic somatic variant identification in ER-positive breast cancer.
Dimitrakopoulos L; Prassas I; Sieuwerts AM; Diamandis EP; Martens JWM; Charames GS
Clin Biochem; 2019 Apr; 66():63-75. PubMed ID: 30684468
[TBL] [Abstract][Full Text] [Related]
14. Mammographic appearance of cancer in the opposite breast: comparison with the first cancer.
Roubidoux MA; Lai NE; Paramagul C; Joynt LK; Helvie MA
AJR Am J Roentgenol; 1996 Jan; 166(1):29-31. PubMed ID: 8571898
[TBL] [Abstract][Full Text] [Related]
15. Integrative Proteo-genomic Analysis to Construct CNA-protein Regulatory Map in Breast and Ovarian Tumors.
Ma W; Chen LS; Özbek U; Han SW; Lin C; Paulovich AG; Zhong H; Wang P
Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S66-S81. PubMed ID: 31281117
[TBL] [Abstract][Full Text] [Related]
16. Bridging the Chromosome-centric and Biology/Disease-driven Human Proteome Projects: Accessible and Automated Tools for Interpreting the Biological and Pathological Impact of Protein Sequence Variants Detected via Proteogenomics.
Sajulga R; Mehta S; Kumar P; Johnson JE; Guerrero CR; Ryan MC; Karchin R; Jagtap PD; Griffin TJ
J Proteome Res; 2018 Dec; 17(12):4329-4336. PubMed ID: 30130115
[TBL] [Abstract][Full Text] [Related]
17. Novel RNA-Affinity Proteogenomics Dissects Tumor Heterogeneity for Revealing Personalized Markers in Precision Prognosis of Cancer.
Wang L; Wrobel JA; Xie L; Li D; Zurlo G; Shen H; Yang P; Wang Z; Peng Y; Gunawardena HP; Zhang Q; Chen X
Cell Chem Biol; 2018 May; 25(5):619-633.e5. PubMed ID: 29503206
[TBL] [Abstract][Full Text] [Related]
18. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection.
Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270
[TBL] [Abstract][Full Text] [Related]
19. Variant peptide detection utilizing mass spectrometry: laying the foundations for proteogenomic identification and validation.
Dimitrakopoulos L; Prassas I; Berns EMJJ; Foekens JA; Diamandis EP; Charames GS
Clin Chem Lab Med; 2017 Aug; 55(9):1291-1304. PubMed ID: 28157690
[TBL] [Abstract][Full Text] [Related]
20. Current Challenges and Implications of Proteogenomic Approaches in Prostate Cancer.
Shukla N; Siva N; Malik B; Suravajhala P
Curr Top Med Chem; 2020; 20(22):1968-1980. PubMed ID: 32703135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
